This 184-page report, “Global Clinical Nutrition Market 2020-2026 by Substrate, Administration Route (Oral or Enteral, Parenteral), End User, Therapeutic Area, Healthcare Setting, Distribution Channel, and Region: Trend Forecast and Growth Opportunity,” is highlighted by 87 tables and 102 figures. It is based on a thorough analysis of the entire global clinical nutrition market and all of its sub-segments through extremely detailed classifications. Premium primary and secondary information sources are used to create in-depth research and evaluation, with input coming from business specialists working throughout the value chain.
By 2026, the global market for clinical nutrition will be worth $77.54 billion, expanding at a rate of 6.64% per year between 2020 and 2026 due to increased rates of chronic communicable and non-communicable illnesses and the COVID-19 pandemic.
The research uses 2019 as the foundation year for its estimate, which ranges from 2020 to 2026 and is based on studies from 2015 to 2019. (Please note that the report will be updated before to delivery to ensure that the forecast includes at least 5 years beyond the base year and the most recent historical year serves as the base year.)
Request Research Sample with Latest Industry Insights: https://altusmarketresearch.com/reports/sample/3469
The following elements are identified and examined in-depth qualitative analyses:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
By taking COVID-19 into consideration, the trend and prognosis for the global market are predicted with an upbeat, fair-minded, and cautious viewpoint. The worldwide clinical nutrition market is estimated using the balanced (most probable) forecast from the viewpoints of substrate, administration route, end user, therapeutic area, healthcare setting, distribution channel, and region.
The worldwide market is divided into the following sub-markets based on Substrate, with annual revenue for 2019–2026 provided in each area.
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global clinical nutrition market in every aspect of the classification from perspectives of Substrate, Administration Route, End User, Therapeutic Area, Healthcare Setting, Distribution Channel, and Region.
Based on Substrate, the global market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.
• Carbohydrates
• Lipids
• Proteins & Amino Acids
• Water & Electrolyte
• Dietary Fiber
• Antioxidants
• Other Substrates
Based on Administration Route, the global market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.
Oral or Enteral Administration
• Oral Nutrition Supplements
• Tube Feeding
Parenteral Administration
• Supplemental Parenteral Nutrition
• Total Parenteral Nutrition
• All-in-One System
• Multiple Bottle System
Based on End User, the global market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.
• Infant
• Children
• Adult
• Geriatrics
Based on Therapeutic Area, the global market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.
• Malnutrition
• Metabolic Disorders
• Gastrointestinal Disorders
• Cancer
• Neurology
• Renal Diseases
• Respiratory Diseases
• Other Therapeutic Areas
Based on Healthcare Setting, the global market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.
• Hospitals
• Long-term Care Facilities (LTC)
• Homecare
• Inpatient Rehabilitation Facilities
• Other Healthcare Settings
Based on Distribution Channel, the global market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.
• Institutional Sales
• Supermarkets & Hypermarkets
• Pharmacies
• Drug Stores
• Online Channels
• Other Distribution Channels
Along with the above national/local markets, the following geographic areas are thoroughly investigated:
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
In Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
• America, North (U.S., Canada, and Mexico)
Latin America (Brazil, Chile, Argentina, Rest of South America)
• MEA (Saudi Arabia, UAE, South Africa)
There are thorough analyses and statistics for yearly revenue for each of the aforementioned regions and nations for the years 2019 through 2026. All regional markets are broken down by country, and major national markets are divided by Administration Route, End User, and Therapeutic Area during the anticipated years.
The study also analyses the present competition landscape, the anticipated trend, and it provides profiles of major suppliers, including both established market leaders and significant up-and-coming companies.
Through AMR’s Risk Assessment System, possible risks related to investments in the global clinical nutrition industry are evaluated quantitatively and qualitatively. Critical Success Factors (CSFs) are developed based on the risk analysis and assessment as a guide to assist investors and shareholders in identifying new possibilities, managing and minimising risks, developing suitable business models, and making informed strategies and choices.
Key Players (this list may not be exhaustive; other businesses may be included upon request):
Abbott Nutrition
B Braun Melsungen Ag
BASF SE
Baxter International Inc.
Claris Lifesciences Ltd.
Fresenius Kabi Ag
Lonza Group AG
Nestle Health Science
Nutricia Ltd
Perrigo Company Plc
